REPORT ID 6240

EMEA (Europe, Middle East and Africa) Anticoagulants Market Report 2017

Publish Date
25-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the EMEA Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Anticoagulants for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anticoagulants market competition by top manufacturers/players, with Anticoagulants sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi
    Bayer
    Boehringer Ingelheim
    Johnson & Johnson
    Genentech (Roche)
    AstraZeneca
    Bristol-Myers Squibb
    Aspen
    Lilly
    Otsuka
    Pfizer
    Daiichi Sankyo
    The Medicines Company

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Platelet aggregation inhibitors (PAI)
    Low-molecular-weight Heparin (LMWH)
    Direct thrombin inhibitor (DTI)
    Direct factor Xa inhibitors (DFXa)
    Vitamin K antagonists (VKA)
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    VTE
    ACS/MI
    AF
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Anticoagulants Market Report 2017
1 Anticoagulants Overview
    1.1 Product Overview and Scope of Anticoagulants
    1.2 Classification of Anticoagulants
        1.2.1 EMEA Anticoagulants Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Anticoagulants Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Platelet aggregation inhibitors (PAI)
        1.2.4 Low-molecular-weight Heparin (LMWH)
        1.2.5 Direct thrombin inhibitor (DTI)
        1.2.6 Direct factor Xa inhibitors (DFXa)
        1.2.7 Vitamin K antagonists (VKA)
        1.2.8 Others
    1.3 EMEA Anticoagulants Market by Application/End Users
        1.3.1 EMEA Anticoagulants Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 VTE
        1.3.3 ACS/MI
        1.3.4 AF
        1.3.5 Other
    1.4 EMEA Anticoagulants Market by Region
        1.4.1 EMEA Anticoagulants Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Anticoagulants (2012-2022)
        1.5.1 EMEA Anticoagulants Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Anticoagulants Revenue and Growth Rate (2012-2022)

2 EMEA Anticoagulants Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Anticoagulants Market Competition by Players/Manufacturers
        2.1.1 EMEA Anticoagulants Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Anticoagulants Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Anticoagulants Sale Price by Players (2012-2017)
    2.2 EMEA Anticoagulants (Volume and Value) by Type/Product Category
        2.2.1 EMEA Anticoagulants Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Anticoagulants Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Anticoagulants Sale Price by Type (2012-2017)
    2.3 EMEA Anticoagulants (Volume) by Application
    2.4 EMEA Anticoagulants (Volume and Value) by Region
        2.4.1 EMEA Anticoagulants Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Anticoagulants Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Anticoagulants Sales Price by Region (2012-2017)

3 Europe Anticoagulants (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Anticoagulants Sales and Value (2012-2017)
        3.1.1 Europe Anticoagulants Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Anticoagulants Revenue and Growth Rate (2012-2017)
    3.2 Europe Anticoagulants Sales and Market Share by Type
    3.3 Europe Anticoagulants Sales and Market Share by Application
    3.4 Europe Anticoagulants Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Anticoagulants Sales Volume by Countries (2012-2017)
        3.4.2 Europe Anticoagulants Revenue by Countries (2012-2017)
        3.4.3 Germany Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.4 France Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.5 UK Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.6 Russia Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.7 Italy Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Anticoagulants Sales and Growth Rate (2012-2017)

4 Middle East Anticoagulants (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Anticoagulants Sales and Value (2012-2017)
        4.1.1 Middle East Anticoagulants Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Anticoagulants Revenue and Growth Rate (2012-2017)
    4.2 Middle East Anticoagulants Sales and Market Share by Type
    4.3 Middle East Anticoagulants Sales and Market Share by Application
    4.4 Middle East Anticoagulants Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Anticoagulants Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Anticoagulants Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Anticoagulants Sales and Growth Rate (2012-2017)
        4.4.4 Israel Anticoagulants Sales and Growth Rate (2012-2017)
        4.4.5 UAE Anticoagulants Sales and Growth Rate (2012-2017)
        4.4.6 Iran Anticoagulants Sales and Growth Rate (2012-2017)

5 Africa Anticoagulants (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Anticoagulants Sales and Value (2012-2017)
        5.1.1 Africa Anticoagulants Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Anticoagulants Revenue and Growth Rate (2012-2017)
    5.2 Africa Anticoagulants Sales and Market Share by Type
    5.3 Africa Anticoagulants Sales and Market Share by Application
    5.4 Africa Anticoagulants Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Anticoagulants Sales Volume by Countries (2012-2017)
        5.4.2 Africa Anticoagulants Revenue by Countries (2012-2017)
        5.4.3 South Africa Anticoagulants Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Anticoagulants Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Anticoagulants Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Anticoagulants Sales and Growth Rate (2012-2017)

6 EMEA Anticoagulants Manufacturers/Players Profiles and Sales Data
    6.1 Sanofi
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Anticoagulants Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bayer
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Anticoagulants Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bayer Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Boehringer Ingelheim
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Anticoagulants Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Boehringer Ingelheim Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Johnson & Johnson
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Anticoagulants Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Johnson & Johnson Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Genentech (Roche)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Anticoagulants Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Genentech (Roche) Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AstraZeneca
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Anticoagulants Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AstraZeneca Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Bristol-Myers Squibb
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Anticoagulants Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Aspen
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Anticoagulants Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Aspen Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Lilly
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Anticoagulants Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Lilly Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Otsuka
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Anticoagulants Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Otsuka Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Pfizer
    6.12 Daiichi Sankyo
    6.13 The Medicines Company

7 Anticoagulants Manufacturing Cost Analysis
    7.1 Anticoagulants Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Anticoagulants

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Anticoagulants Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Anticoagulants Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Anticoagulants Market Forecast (2017-2022)
    11.1 EMEA Anticoagulants Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Anticoagulants Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Anticoagulants Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Anticoagulants Price and Trend Forecast (2017-2022)
    11.2 EMEA Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Anticoagulants Sales Forecast by Type (2017-2022)
    11.7 EMEA Anticoagulants Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer